Oral & Mucosal Adjuvant as an Immunostimulant Against HIV

Keyphrases

• Arizona State University 33%
• Bioactive Peptides 33%
• Cholera Toxin B 100%
• Edible Tissues 33%
• Effective Alternatives 33%
• Epithelial Cells 33%
• High Titer 33%
• Immune Response 33%
• Immunogenic 33%
• Immunogenicity 33%
• Immunomodulatory Drugs (IMiDs) 33%
• Immunostimulant 100%
• Immunostimulatory 33%
• Lectin 33%
• Live Attenuated 33%
• Mucosal Adjuvant 100%
• Mucosal Epithelial Cells 33%
• Mucosal Immune Response 33%
• Mucosal Vaccine 33%
• Oral Adjuvant 100%
• Oral Immunotherapy 33%
• Oral Ingestion 33%
• Oral mucosa 100%
• Orally Active 33%
• Safer Alternatives 33%
• Subunit Vaccine 33%
• Transcytosis 33%
• Transgenic Plants 33%
• α-galactosylceramide (α-GalCer) 33%

Medicine and Dentistry

• Adjuvant 16%
• Cholera Toxin B Subunit 50%
• Diseases 16%
• Epithelial Cell 33%
• Galactosylceramide 16%
• Human Immunodeficiency Virus 100%
• Immune Response 16%
• Immunogenicity 16%
• Immunostimulating Agent 100%
• Ingestion 16%
• Injection 33%
• Lectin 16%
• Mucosal Immune System 16%
• Mucosal Vaccine 16%
• Oral 100%
• Pathogen 16%
• Peptide 100%
• Subunit Vaccine 33%
• Transcytosis 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Adjuvant 16%
• Cholera Toxin B Subunit 50%
• Diseases 16%
• Galactosylceramide 16%
• HIV 100%
• Immunogenicity 16%
• Immunostimulant 100%
• Infectious Agent 16%
• Lectin 16%
• Mucosal Vaccine 16%
• Peptide 100%
• Subunit Vaccine 33%
• Transcytosis 16%
• Transgenic Plant 16%